Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

October 11, 2015

Teriflunomide (AUBAGIO) Slows Brain Atrophy in Relapsing Multiple Sclerosis

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
Oct 9, 2015 BARCELONA — A reanalysis of phase III data on teriflunomide (Aubagio) shows that both doses of the…
MS Drug Therapies

October 11, 2015

Tysabri vs. Gilenya: Studies Conflict on Which Is Superior

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
Is natalizumab better than fingolimod? Flip a coin   by John Gever Managing Editor, MedPage Today BARCELONA — Results from two European…
MS Drug Therapies

October 11, 2015

Vitamin D Supplements Improve Cognition in Patients With MS

  • Multiple Sclerosis
    /
  • Vitamins and Supplements
    /
BARCELONA — Patients with multiple sclerosis (MS) given vitamin D supplements showed improved cognition at 3 months, a new study…
Multiple Sclerosis

October 11, 2015

Effect of comorbidity on mortality in multiple sclerosis

  • MS Research Study and Reports
    /
Objective: We aimed to compare survival in the multiple sclerosis (MS) population with a matched cohort from the general population, and…
MS Research Study and Reports

October 11, 2015

THE ROLE OF B AND T CELLS IN MULTIPLE SCLEROSIS – Shining a LIGHT on MS

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
SHINING A LIGHT ON MULTIPLE SCLEROSIS More than 2 million people worldwide are affected by multiple sclerosis (MS).1 Genentech is committed to understanding MS. Learn…
MS Drug Therapies

October 11, 2015

Tried-and-True Antibiotic May Block Conversion to MS

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
Minocycline seemed to reduce progression to multiple sclerosis after first demyelinating event BARCELONA — After a first demyelinating event, a…
MS Drug Therapies

October 11, 2015

‘Every Day We Are So Grateful That We Are Not in This Race’

  • An MS Patients Story
    /
  • Multiple Sclerosis
    /
Ann Romney, wife of former Republican presidential candidate Mitt Romney, speaks at a rally in St. Augustine, Florida in October…
An MS Patients Story

October 11, 2015

Ocrelizumab: Experts Question Magnitude of Benefit in PPMS

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
ORATORIO trial results positive, but not impressive enough BARCELONA — Enthusiasm for ocrelizumab was tempered after positive results from the…
MS Drug Therapies

October 10, 2015

Genzyme Provides Update on Lemtrada for Patients with Relapsing-Remitting Multiple Sclerosis, ECTRIMS 2015

  • MS Drug Therapies
    /
Genzyme, a Sanofi company, recently announced novel positive 5-year experimental data from the extension study of Lemtrada® (alemtuzumab) in individuals with relapsing-remitting multiple sclerosis (RRMS).…
MS Drug Therapies

October 10, 2015

COMPLETE this global employment survey to find out how MS affects employment

  • Additional MS resource sites
    /
  • Caregiver related
    /
  • For the Benefit of the Patient
    /
The MS International Federation (MSIF) is fielding a global employment survey to find out how MS affects employment. The results…
Additional MS resource sites

Categories

Latest Blog Posts